Category list

Charles Berman

Charles Berman is a principal shareholder with the law firm Greenberg Traurig, LLP, in Santa Monica, California, and he is Co-Chair of the national patent prosecution practice of the firm. He has been active in all areas of intellectual property law for more than 35 years . He has been practicing in Los Angeles since 1978, and practiced in South Africa prior to that time. He has also worked with European patent attorneys .

Berman has extensive IP experience in the United States and foreign countries and has been involved in the U.S. and international licensing of technology. Berman has represented large corporations in actions before the U.S. Patent Office, the European Patent Office, and the German, Japanese, and other major patent offices. He has engaged in major international patent and trademark procurement programs for leading corporations.

Berman currently serves as Chair of Fellows of the American Intellectual Property Law Association (AIPLA), where he was a founding fellow, and has also served on the board of directors. He has held several prominent positions over the past several years in the AIPLA, including being a representative for international meetings. He has been President of the Los Angeles Intellectual Property Law Association.

He is a frequently invited speaker, has written numerous articles on the topic of intellectual property, and has been on the editorial boards of different intellectual property publications . Berman was educated at the University of Witwatersrand in South Africa.

Jeff Lawrence

Jeff Lawrence is President & CEO of Clivia Systems (www.cliviasystems.com), former CTO of Intel's Network Communications Group, and co-founder and former President and CEO of Trillium Digital Systems. Trillium was a leading provider of communications software solutions to communications equipment manufacturers building the converged wireless, Internet, broadband, and telephone infrastructure. Trillium licensed its source code software solutions to more than 300 companies throughout the world for use in a wide range of telecommunications products. Trillium's solutions consisted of software products and services for data, voice, and high availability. Lawrence, along with his team, built Trillium from two people, zero products, zero revenue, and $1,000 initially invested capital at its founding in February 1988 to more than 250 people, more than 100 products consisting of millions of lines of source code, $30 million annual revenue, and acquisition by Intel in August 2000 for $300 million. Jeff led, built, motivated, and grew a team having a unique and deep understanding of the communications software industry and having a culture and commitment to the customer and success during a period of continual and rapid change in the technology, market, competitive, and financial environment.

Lawrence is also Trustee of The Lawrence Foundation (www.thelawrencefoundation.org), a family foundation focused on grant making to environmental, education, health, and human services causes. He has a B.S.E.E. from UCLA, was co-recipient of the Greater Los Angeles Entrepreneur of the Year award, and recipient of the UCLA School of Engineering's Professional Achievement award. Jeff also writes and speaks on technology, entrepreneurship, philanthropy, economics, and ethics.

Larry Bock

Larry Bock is the Founder and Executive Chairman of Nanosys Inc. He is a General Partner of CW Ventures, a life sciences venture capital fund, and a Special Advisor to Lux Capital, a nanotechnology-focused venture capital fund. He is a member of the board of directors of FEI Corporation, the leading supplier of tools for nanotechnology research.

Bock was the Founder and initial CEO of Neurocrine Biosciences, Pharmacopeia, GenPharm International, Caliper Technologies, Illumina Technologies, IDUN Pharmaceuticals, Metra Biosystems, and FASTTRACK Systems. Bock was a co-founder of Argonaut Technologies, ARIAD Pharmaceuticals, Athena Neurosciences, Vertex Pharmaceuticals, and Onyx Pharmaceuticals. He also helped found and is on the scientific advisory board of Conforma Therapeutics.

Bock started his career as a Researcher at Genentech, Inc., in the field of infectious diseases, where he was on the team that received the AAAS Newcomb Cleveland Prize for demonstrating the first recombinant DNA vaccine.

He has received several awards and honors. He was selected by Venture Capital Journal as one of the "Ten Most Influential Venture Capitalists," by Red Herring as one of the "Top Ten Innovators," by Forbes-Wolfe NanoReport as the "Number One Powerbroker in Nanotechnology," by Ernst & Young as a finalist for "Entrepreneur of the Year," and by Small Times as "Innovator of the Year" and one of "Top 3 Business Leaders of the Year." He received the Einstein Award from the Jerusalem Foundation for lifetime contributions in the field of life sciences.

Bock and his wife, Diane, founded Community Cousins, a nonprofit foundation focused on breaking down racial barriers, which was selected by former Vice President Al Gore as one of ten outstanding grassroots efforts nationally. Bock received his B.A. in biochemistry from Bowdoin College and his M.B.A. from the Anderson School at UCLA.

Flylib.com

Category list

Similar pages

Charles Berman

Charles Berman

Jeff Lawrence

Larry Bock

Similar products

Similar products